We are live on ! Find out more
LFCR icon

Lifecore Biomedical
LFCR

91 hedge funds and large institutions have $323M invested in Lifecore Biomedical in 2019 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 30 increasing their positions, 28 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more funds holding in top 10

Funds holding in top 10: 1 → 2 (+1)

25% more first-time investments, than exits

New positions opened: 10 | Existing positions closed: 8

5% more capital invested

Capital invested by funds: $306M → $323M (+$16.7M)

2% more funds holding

Funds holding: 89 → 91 (+2)

7% more repeat investments, than reductions

Existing positions increased: 30 | Existing positions reduced: 28

2.94% less ownership

Funds ownership: 93.14% → 90.21% (-2.9%)

Holders
91
Holders Change
+2
Holders Change %
+2.25%
% of All Funds
1.97%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.04%
New
10
Increased
30
Reduced
28
Closed
8
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
WC
Walthausen & Co
New York
+$4.25M
2
PCM
Penn Capital Management
Pennsylvania
+$3.31M
3
Russell Investments Group
Russell Investments Group
United Kingdom
+$2.61M
4
AC
AltraVue Capital
Washington
+$1.67M
5
LCM
Legato Capital Management
California
+$1.06M

Top Sellers

Rank Fund Capital Flow
1
RA
Royce & Associates
New York
-$6.3M
2
NC
Northpointe Capital
Michigan
-$2.6M
3
BlackRock
BlackRock
New York
-$1.88M
4
Morgan Stanley
Morgan Stanley
New York
-$1.09M
5
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
-$980K
Name Holding Trade Value Shares
Change 		Change in
Stake
PCM
26
Perritt Capital Management
Illinois
$2.29M -$244K -20,000 -10%
LCM
27
Legato Capital Management
California
$2.16M +$1.06M +86,890 +97%
MAM
28
Martingale Asset Management
Massachusetts
$2M +$553K +45,287 +39%
Charles Schwab
29
Charles Schwab
California
$1.9M +$33.8K +2,766 +2%
NSIM
30
North Star Investment Management
Illinois
$1.81M +$272K +22,300 +18%
Renaissance Technologies
31
Renaissance Technologies
New York
$1.79M +$127K +10,400 +8%
RHJA
32
Rice Hall James & Associates
California
$1.48M -$397K -32,485 -21%
CIP
33
Chartwell Investment Partners
Pennsylvania
$1.42M +$64.6K +5,291 +5%
Bank of America
34
Bank of America
North Carolina
$1.35M -$52.3K -4,280 -4%
AA
35
Ancora Advisors
Ohio
$1.34M -$8.55K -700 -0.6%
Bessemer Group
36
Bessemer Group
New Jersey
$1.19M +$469K +38,400 +66%
California Public Employees Retirement System
37
California Public Employees Retirement System
California
$786K – – –
Boston Partners
38
Boston Partners
Massachusetts
$752K +$748K +61,239 New
GIP
39
Granite Investment Partners
California
$727K +$190K +15,572 +36%
IA
40
IndexIQ Advisors
New York
$714K +$710K +58,174 New
TCIM
41
TIAA CREF Investment Management
New York
$689K -$8.84K -724 -1%
First Trust Advisors
42
First Trust Advisors
Illinois
$653K +$38.5K +3,150 +6%
Goldman Sachs
43
Goldman Sachs
New York
$588K -$176K -14,438 -23%
TA
44
Teachers Advisors
New York
$586K – – –
JGC
45
J. Goldman & Co
New York
$570K -$422K -34,595 -43%
Swiss National Bank
46
Swiss National Bank
Switzerland
$558K – – –
Two Sigma Investments
47
Two Sigma Investments
New York
$546K +$543K +44,501 New
State Board of Administration of Florida Retirement System
48
State Board of Administration of Florida Retirement System
Florida
$543K – – –
Millennium Management
49
Millennium Management
New York
$499K +$497K +40,671 New
RhumbLine Advisers
50
RhumbLine Advisers
Massachusetts
$483K +$10.8K +884 +2%
1
2
3 4

LFCR Hedge Fund Activity: Q1 2019 in Review

91 of the 4,620 institutional investors tracked by Wall St. Rank reported a position in Lifecore Biomedical (LFCR) for Q1 2019, worth a combined $323M — up 5.4% from $306M a quarter earlier.

Buyers outnumbered sellers: 10 funds opened new LFCR positions and 8 closed out — a net gain of 2 holders — while 30 added to existing stakes and 28 trimmed.

The largest buyer was Walthausen & Co, adding an estimated $4.25M. The largest seller was Royce & Associates, cutting an estimated $6.3M.

  • 91 institutional investors held Lifecore Biomedical (LFCR) as of Q1 2019, up from 89 in Q4 2018.
  • Funds reported $323M of Lifecore Biomedical stock for Q1 2019, up 5.4% quarter-over-quarter.
  • 10 funds opened new Lifecore Biomedical positions in Q1 2019 and 8 closed out, a net change of +2 holders.
  • The largest Lifecore Biomedical buyer in Q1 2019 was Walthausen & Co, an estimated $4.25M added.
  • The largest Lifecore Biomedical seller in Q1 2019 was Royce & Associates, an estimated $6.3M sold.

Based on aggregated 13F filings for Q1 2019.